Phase 2 clinical trial of CP-COV03 for Influenza
Latest Information Update: 14 Dec 2021
At a glance
- Drugs Niclosamide (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 14 Dec 2021 New trial record
Latest Information Update: 14 Dec 2021